WHO may drop ‘counterfeit’ from its substandard drugs definition; move won't affect national legislation

The World Health Organisation is considering a recommendation that it drops use of the term ‘counterfeit’ when referring to drugs and other medical products that appear to fail regulatory standards and lack relevant approvals.

Get unlimited access to all WTR content